Literature DB >> 19776143

Intermittent fasting does not affect whole-body glucose, lipid, or protein metabolism.

Maarten R Soeters1, Nicolette M Lammers, Peter F Dubbelhuis, Mariëtte Ackermans, Cora F Jonkers-Schuitema, Eric Fliers, Hans P Sauerwein, Johannes M Aerts, Mireille J Serlie.   

Abstract

BACKGROUND: Intermittent fasting (IF) was shown to increase whole-body insulin sensitivity, but it is uncertain whether IF selectively influences intermediary metabolism. Such selectivity might be advantageous when adapting to periods of food abundance and food shortage.
OBJECTIVE: The objective was to assess effects of IF on intermediary metabolism and energy expenditure.
DESIGN: Glucose, glycerol, and valine fluxes were measured after 2 wk of IF and a standard diet (SD) in 8 lean healthy volunteers in a crossover design, in the basal state and during a 2-step hyperinsulinemic euglycemic clamp, with assessment of energy expenditure and phosphorylation of muscle protein kinase B (AKT), glycogen synthase kinase (GSK), and mammalian target of rapamycine (mTOR). We hypothesized that IF selectively increases peripheral glucose uptake and lowers proteolysis, thereby protecting protein stores.
RESULTS: No differences in body weight were observed between the IF and SD groups. Peripheral glucose uptake and hepatic insulin sensitivity during the clamp did not significantly differ between the IF and SD groups. Likewise, lipolysis and proteolysis were not different between the IF and SD groups. IF decreased resting energy expenditure. IF had no effect on the phosphorylation of AKT but significantly increased the phosphorylation of glycogen synthase kinase. Phosphorylation of mTOR was significantly lower after IF than after the SD.
CONCLUSIONS: IF does not affect whole-body glucose, lipid, or protein metabolism in healthy lean men despite changes in muscle phosphorylation of GSK and mTOR. The decrease in resting energy expenditure after IF indicates the possibility of an increase in weight during IF when caloric intake is not adjusted. This study was registered at www.trialregister.nl as NTR1841.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776143     DOI: 10.3945/ajcn.2008.27327

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  33 in total

Review 1.  Intermittent Fasting: Is the Wait Worth the Weight?

Authors:  Mary-Catherine Stockman; Dylan Thomas; Jacquelyn Burke; Caroline M Apovian
Journal:  Curr Obes Rep       Date:  2018-06

Review 2.  Impact of intermittent fasting on health and disease processes.

Authors:  Mark P Mattson; Valter D Longo; Michelle Harvie
Journal:  Ageing Res Rev       Date:  2016-10-31       Impact factor: 10.895

Review 3.  Intermittent Fasting and Metabolic Health: From Religious Fast to Time-Restricted Feeding.

Authors:  Kristin K Hoddy; Kara L Marlatt; Hatice Çetinkaya; Eric Ravussin
Journal:  Obesity (Silver Spring)       Date:  2020-07       Impact factor: 5.002

4.  Transcriptome analysis of peripheral blood mononuclear cells in human subjects following a 36 h fast provides evidence of effects on genes regulating inflammation, apoptosis and energy metabolism.

Authors:  R M Elliott; B de Roos; S J Duthie; F G Bouwman; I Rubio-Aliaga; L K Crosley; C Mayer; A C Polley; C Heim; S L Coort; C T Evelo; F Mulholland; H Daniel; E C Mariman; I T Johnson
Journal:  Genes Nutr       Date:  2014-09-27       Impact factor: 5.523

5.  Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes.

Authors:  Elizabeth F Sutton; Robbie Beyl; Kate S Early; William T Cefalu; Eric Ravussin; Courtney M Peterson
Journal:  Cell Metab       Date:  2018-05-10       Impact factor: 27.287

Review 6.  Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence.

Authors:  Michelle N Harvie; Tony Howell
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

7.  Intermittent fasting for the prevention of cardiovascular disease.

Authors:  Mohammed Allaf; Hussein Elghazaly; Omer G Mohamed; Mohamed Firas Khan Fareen; Sadia Zaman; Abdul-Majeed Salmasi; Kostas Tsilidis; Abbas Dehghan
Journal:  Cochrane Database Syst Rev       Date:  2021-01-29

8.  Bath Breakfast Project (BBP)--examining the role of extended daily fasting in human energy balance and associated health outcomes: study protocol for a randomised controlled trial [ISRCTN31521726].

Authors:  James A Betts; Dylan Thompson; Judith D Richardson; Enhad A Chowdhury; Matthew Jeans; Geoffrey D Holman; Kostas Tsintzas
Journal:  Trials       Date:  2011-07-08       Impact factor: 2.279

Review 9.  Calorie restriction for enhanced longevity: The role of novel dietary strategies in the present obesogenic environment.

Authors:  James L Dorling; Corby K Martin; Leanne M Redman
Journal:  Ageing Res Rev       Date:  2020-02-25       Impact factor: 11.788

10.  The effect of a diiodothyronine mimetic on insulin sensitivity in male cardiometabolic patients: a double-blind randomized controlled trial.

Authors:  Fleur van der Valk; Carlijne Hassing; Maartje Visser; Purav Thakkar; Anookh Mohanan; Kaushal Pathak; Chaitanya Dutt; Vijay Chauthaiwale; Mariette Ackermans; Aart Nederveen; Mireille Serlie; Max Nieuwdorp; Erik Stroes
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.